Pacing in hypertrophic cardiomyopathy

Cardiology Clinics

Volumn 18, Issue 1, 2000, Pages 67-79

  Sorajja, Paul ^b   Elliott, Perry M ^b   McKenna, William J ^b  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CIBENZOLINE; DISOPYRAMIDE; VERAPAMIL;

CLINICAL TRIAL; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART PACING; HEART SURGERY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MUSCLE RESECTION; PRIORITY JOURNAL; REVIEW;

EID: 0033951170     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(05)70128-4     Document Type: Article

References (66)

1. G. Amitzur D. Manor A. Pressman Modulation of the arterial coronary blood flow by asynchronous activation with ventricular pacing PACE 18 [Pt. I 1995 697 710
2. Betocchi S. Losi M.-A. F. Piscione Effects of dual-chamber pacing in hypertrophic cardiomyopathy on left ventricular outflow tract obstruction and on diastolic function Am J Cardiol 77 1996 498 502
3. R.O. Bonow V. Dilsizian D.R. Rosing Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: Short- and long-term effects Circulation 72 1985 853 864
4. J.M. Criley Unobstructed thinking (and terminology) is called for in the understanding and management of hypertrophic cardiomyopathy J Am Coll Cardiol 29 1997 741 743
5. J.M. Criley K.B. Lewis White R.I. Jr Pressure gradients without obstruction: A new concept of “hypertrophic subaortic stenosis” Circulation 32 1965 887 881
6. H.J. Duck W. Hutschenreiter H. Pankau Vorhofsynchione ventrikelstimulation mit verhürtzer a.v. versögerungszeit als therapieprinzip der hypertrophischen obstruktiven kardiomyopathie Z Gesamte Inm Med 39 1984 437 447
7. G. Duport B. Valeix J. Lefevre Intérêt de la stimulation ventriculaire droite permanente dans la cardiomyopathie obstructive Nouv Presse Med 32 1978 2868 2869
8. L. Fananapazir R.O. Cannon D. Tripodi Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and β-adrenergic blocker therapy Circulation 85 1992 2149 2161
9. L. Fananapazir N.D. Epstein R.V. Curiel Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy: Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy Circulation 90 1994 2731 2742
10. W.H. Gaasch A.S. Blaunstein C.W. Andrias Myocardial relaxation II: Hemodynamic determinants of rate of left ventricular isovolumic pressure decline Am J Physiol 239 1980 H1 H6
11. F. Gadler C. Linde A. Juhlin-Dannfeldt Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy J Am Coll Cardiol 27 1996 1219 1224
12. J.M. Gilgenkrantz F. Cherrier H. Petitier Cardiomyopathie obstructive du ventricule gauche avec bloc auriculo-ventriculaire complet: Considérations thérapeutiques Arch Mal Coeur 60 1968 439 453
13. D. Gras C. Leclercg De Place C. The potential role of dual chamber pacing in the management of elderly patients with hypertrophic cardiomyopathy Cardiol Elderly 3 1995 430 438
14. J.N. Gross T.N. Keltz J.A. Cooper Profound “pacemaker syndrome” in hypertrophic cardiomyopathy Am J Cardiol 70 1992 1507 1511
15. M. Hamada Y. Shigematsu S. Ikeda Class Ia antiarrhythmic drug cibenzoline: A new approach to the medical treatment of hypertrophic obstructive cardiomyopathy Circulation 96 1997 1520 1524
16. V.P. Hassenstein H.H. Wolter Therapeutische beherrschung einer bedrohlichen situation bei der idiopathischen hypertrophischen subaortenstenose Verh Dtsch Ges Kreislaufforsch 33 1967 242 246
17. B. Heric B.W. Lytle D.P. Miller Surgical management of hypertrophic obstructive cardiomyopathy: Early and late results J Thorac Cardiovasc Surg 110 1995 195 208
18. M.C. Iliou T.L. Laverne A.C. Hernigou Lack of left ventricular mass reduction six months after dual chamber pacing implantation in obstructive hypertrophic cardiomyopathy Circulation 90 Suppl I 1994 I 655A
19. M.C. Iliou T.L. Laverne A. Hernigou Left ventricular remodeling by long-term dual-chamber pacing in hypertrophic obstructive cardiomyopathy Circulation 94 Suppl I 1996 I 361A
20. X. Jeanrenaud Left ventricular wall-motion changes during eccentric ventricular activation in hypertrophic obstructive cardiomyopathy patients J Interven Cardiol 9 1996 327 333
21. Jeanrenaud X. Goy J.-J. L. Kappenberger Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy Lancet 339 1992 1318 1323
22. X. Jeanrenaud L. Kappenberger Regional wall motion during pacing for hypertrophic obstructive cardiomyopathy PACE 20 1997 1673 1681
23. X. Jeanrenaud J. Schlöpfer M. Fromer Dual chamber pacing in hypertrophic obstructive cardiomyopathy: Beneficial effect of atrioventricular junction ablation for optimal left ventricular capture and filling PACE 20 Pt. I 1997 293 300
24. A.D. Johnson P.O. Daily Hypertrophic subaortic stenosis complicated by high degree heart block: Successful treatment with an atrial synchronous ventricular pacemaker Chest 67 1975 491 494
25. L. Kappenberger C. Linde C. Daubert Pacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study Europ Heart J 18 1997 1249 1256
26. C. Knight A.S. Kurbann H. Seggewiss Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy: Outcome in the first series of patients Circulation 95 1997 2075 2081
27. M.A. Lee M.W. Dae J.J. Langberg Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function, and histology J Am Coll Cardiol 24 1994 255 232
28. R.A. Levine X. Lefebvre J.L. Guerrero Unifying concepts of mitral valve function and disease: SAM, prolapse, and ischemic mitral regurgitation J Cardiology 24 Suppl 38 1994 15 27
29. R.A. Levine G.J. Vlahakes X. Lefebvre Papillary muscle displacement causes systolic anterior motion of the mitral valve: Experimental validation and insights into the mechanism of subaortic obstruction Circulation 91 1995 1189 1195
30. B.J. Maron J.M. Gardin J.M. Flack Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA study Circulation 92 1995 785 789
31. B.J. Maron W.H. Merrill P.A. Freier Long-term clinical course and symptomatic status of patients after operation of hypertrophic subaortic stenosis Circulation 57 1978 1205 1213
32. B.J. Maron R.A. Nishimura W.J. McKenna Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: A randomized, double-blind, cross-over study (M-PATHY) Circulation 99 1999 2927 2933
33. B.J. Maron Appraisal of dual-chamber pacing therapy in hypertrophic cardiomyopathy: Too soon for a rush to judgment? J Am Coll Cardiol 27 1996 431 432
34. B.J. Maron Hypertrophic cardiomyopathy Lancet 350 1997 127 130
35. D. McAreavey L. Fananapazir Altered cardiac hemodynamic and electrical state in normal sinus rhythm after chronic dual-chamber pacing for relief of left ventricular outflow obstruction in hypertrophic cardiomyopathy Am J Cardiol 70 1992 651 656
36. R.B. McCully R.A. Nishimura A.J. Tajik Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy Circulation 94 1996 467 471
37. K. McDonald E. McWilliams B. O'Keefe Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy Europ Heart J 9 1988 893 898
38. C.L. McIntosh G.J. Greenberg B.J. Maron Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy Ann Thorac Surg 47 1989 236 246
39. R. Mohr H.V. Schaff G.K. Danielson The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy: Experience over 15 years J Thorac Cardiovasc Surg 97 1989 666 674
40. A.G. Morrow B.A. Reitz S.E. Epstein Operative treatment in hypertrophic subaortic stenosis: Techniques, and the results of pre- and postoperative assessments in 83 patients Circulation 52 1975 88 101
41. J.P. Murgo B.R. Alter J.F. Dorethy Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy J Clin Invest 66 1980 1369 1382
42. S.F. Nagueh N.M. Lakkis K.J. Middleton Circulation 99 1999 347 344
43. R.A. Nishimura D.L. Hayes D.M. Ilstrup Effect of dual-chamber pacing on systolic and diastolic function in patients with hypertrophic cardiomyopathy J Am Coll Cardiol 27 1996 421 430
44. R.A. Nishimura J.M. Trusty D.L. Hayes Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double-blind, crossover trial J Am Coll Cardiol 29 1997 435 441
45. S.H. Park C. Shub T.P. Nobrega Two-dimensional echocardiographic calculation of left ventricular mass as recommended by the American Society of Echocardiography: correlation with autopsy and M-mode echocardiography J Am Soc Echocardiogr 9 1996 119 128
46. C. Pollick B. Kimball M. Henderson Disopyramide in hypertrophic cardiomyopathy I: Hemodynamic assessment after intravenous administration Am J Cardiol 62 1988 1248 1251
47. C. Pollick H. Rakowski E.D. Wigle Muscular subaortic stenosis: The quantitative relationship between systolic anterior motion and the pressure gradient Circulation 69 1984 43 49
48. J.L. Posma P.K. Blanksma van der Wall E.E. Redistribution of myocardial perfusion during permanent dual chamber pacing in symptomatic nonobstructive hypertrophic cardiomyopathy: A quantitative positron emission tomography study Heart 75 1996 522 524
49. J.L. Posma P.K. Blanksma van der Wall E.E. Effects of permanent dual chamber pacing on myocardial perfusion in symptomatic hypertrophic cardiomyopathy Heart 76 1996 358 362
50. F.W. Prinzen C.H. Augustijn T. Arts Redistribution of myocardial fiber strain and blood flow by asynchronous activation Am J Physio 259 1990 H300 H308
51. R.C. Robbins E.B. Stinson Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy J Thorac Cardiovasc Surg 111 1996 586 594
52. M. Rothlin T. Mocetti Beeinflussung der muskulären subaottenstenose durch intraventrikuläre reizausbreitung Verh Dtsch Ges Kreilaufforsch 37 1971 411 415
53. H.D. Schulte W.H. Bircks B. Loesse Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy: Late results up to twenty-five years J Thorac Cardiovasc Surg 106 1993 709 717
54. H. Seggewiss U. Gleichmann L. Faber Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and 3-month follow-up in 25 patients J Am Coll Cardiol 31 1998 252 258
55. C. Seiler O.M. Hess M. Schoenbeck Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: A retrospective study J Am Coll Cardio 17 1991 634 642
56. F.A. Schoendube H.G. Klues S. Reith Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus Circulation 92 [suppl II 1995 II-122 II-127
57. M.V. Sherrid G. Pearle D.Z. Gunsburg Mechanism of benefit of negative inotropes in obstructive hypertrophic cardiomyopathy Circulation 97 1998 41 47
58. A.K.B. Slade N. Sadoul L. Shapiro DDD pacing in hypertrophic cardiomyopathy: A multicentre clinical experience Heart 75 1996 44 49
59. P. Spirito C.E. Seidman W.J. McKenna The management of hypertrophic cardiomyopathy N Engl J Med 336 1997 775 785
60. Ten Berg J.M. M.J. Suttorp P.J. Knaepen Hypertrophic obstructive cardiomyopathy: Initial results and long-term follow-up after Morrow septal myectomy Circulation 90 1994 1781 1785
61. Ten Berg J.M. Van Tooren R. W. Jaarsma Therapeutic options in patients with obstructive hypertrophic cardiomyopathy and severe drug-refractory symptoms J Am Coll Cardiol 32 1998 1485
62. C.H. Thompson G.J. Kemp D.J. Taylor Abnormal skeletal muscle bioenergetics in familial hypertrophic cardiomyopathy Heart 78 1997 177 181
63. E.D. Wigle Z. Sasson M.A. Henderson Hypertrophic cardiomyopathy: The importance of the site and extent of hypertrophy: A review Prog Cardiovasc Dis 28 1985 1 83
64. W.G. Williams E.D. Wigle H. Rakowski Results of surgery for hypertrophic obstructive cardiomyopathy Circulation 76 suppl V 1987 V-104 V-108
65. M. Wish R.D. Fletcher J.S. Gottdiener Importance of left atrial timing in the programming of dual-chamber pacemakers Am J Cardiol 60 1987 566 571
66. M.R. Zile A.S. Blaustein G. Shimizu Right ventricular pacing reduces the rate of left ventricular relaxation and filling J Am Coll Cardiol 10 1987 702 709